{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:32:56Z","timestamp":1794897176610,"version":"4.9.1"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00705","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T04:33:42Z","timestamp":1543293222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":165,"title":["The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality"],"prefix":"10.3389","volume":"9","author":[{"given":"Shejil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Samaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harbor Perspect Med."},{"key":"B2","unstructured":"Fact Sheet\u2014Latest Statistics on the Status of the AIDS Epidemic2018"},{"key":"B3","first-page":"B5210","article-title":"The road to success","volume":"63","author":"Lohse","year":"2016","journal-title":"Danish Med J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1741-7015-11-251","article-title":"Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?","volume":"11","author":"Sabin","year":"2013","journal-title":"BMC Med."},{"key":"B5","unstructured":"Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV2015"},{"key":"B6","unstructured":"2812322390-90-90: Treatment for All2018"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e21919","DOI":"10.1371\/journal.pone.0021919","article-title":"The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa","volume":"6","author":"Hontelez","year":"2011","journal-title":"PLoS ONE"},{"key":"B8","unstructured":"DepartmentWHOHA\n          New WHO Recommendations: Antiretroviral Therapy for Adults and Adolescents2018"},{"key":"B9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/COH.0000000000000008","article-title":"The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities","volume":"8","author":"Doherty","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1001907","DOI":"10.1371\/journal.pmed.1001907","article-title":"The HIV treatment gap: estimates of the financial resources needed versus available for scale-up of antiretroviral therapy in 97 countries from 2015 to 2020","volume":"12","author":"Dutta","year":"2015","journal-title":"PLoS Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1097\/QAD.0000000000000864","article-title":"HIV treatment cascades: how can all countries reach the UNAIDS 90-90-90 target?","volume":"29","author":"Hill","year":"2015","journal-title":"AIDS"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/EDE.0000000000000815","article-title":"Incidence and risk factors for prediabetes and diabetes mellitus among HIV infected adults on antiretroviral therapy: systematic review and meta-analysis","volume":"29","author":"Nansseu","year":"2018","journal-title":"Epidemiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/429697","article-title":"In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA","volume":"191","author":"Mallon","year":"2005","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3851\/IMP2348","article-title":"HIV infection and obesity: where did all the wasting go?","volume":"17","author":"Tate","year":"2012","journal-title":"Antiviral Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1038\/sj.ijo.0803516","article-title":"The thrifty \u2018catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome","volume":"30","author":"Dulloo","year":"2006","journal-title":"Int J Obes."},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/apc.2008.0082","article-title":"Obesity among patients with HIV: the latest epidemic","volume":"22","author":"Crum-Cianflone","year":"2008","journal-title":"AIDS Patient Care STDs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e10106","DOI":"10.1371\/journal.pone.0010106","article-title":"Increasing rates of obesity among HIV-infected persons during the HIV epidemic","volume":"5","author":"Crum-Cianflone","year":"2010","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1097\/00002030-199912030-00010","article-title":"Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients","volume":"13","author":"Pernerstorfer-Schoen","year":"1999","journal-title":"AIDS"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/00002030-199814000-00009","article-title":"Effect of indinavir on HIV-related wasting","volume":"12","author":"Carbonnel","year":"1998","journal-title":"AIDS"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1097\/00002030-199813000-00012","article-title":"The effect of protease inhibitors on weight and body composition in HIV-infected patients","volume":"12","author":"Silva","year":"1998","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1086\/498022","article-title":"CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study","volume":"41","author":"McDermott","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1086\/375889","article-title":"Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort","volume":"37","author":"Jones","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1097\/QAI.0000000000000010","article-title":"High risk of obesity and weight gain for HIV-infected uninsured minorities","volume":"65","author":"Taylor","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/aid.2012.0234","article-title":"Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons","volume":"29","author":"Lakey","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1089\/jwh.2017.6717","article-title":"HIV-infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy","volume":"27","author":"Bares","year":"2018","journal-title":"J Women's Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/infdis\/jiw096","article-title":"Inflammation and change in body weight with antiretroviral therapy initiation in a multinational cohort of HIV-infected adults","volume":"214","author":"Mave","year":"2016","journal-title":"J Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1086\/424665","article-title":"Changes in weight and lean body mass during highly active antiretroviral therapy","volume":"39","author":"Shikuma","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/QAD.0b013e328361d25d","article-title":"Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density","volume":"27","author":"Erlandson","year":"2013","journal-title":"AIDS"},{"key":"B34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/hiv.12294","article-title":"Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study","volume":"17","author":"Achhra","year":"2016","journal-title":"HIV Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11904-011-0087-3","article-title":"Management of fat accumulation in patients with HIV infection","volume":"8","author":"Falutz","year":"2011","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5501\/wjv.v4.i2.56","article-title":"Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: old and new drugs","volume":"4","author":"da Cunha","year":"2015","journal-title":"World J Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.metabol.2013.04.014","article-title":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","volume":"62","author":"Paruthi","year":"2013","journal-title":"Metabolism"},{"key":"B38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med."},{"key":"B39","first-page":"127","article-title":"Pathogenesis and treatment of lipodystrophy: what clinicians need to know","volume":"16","author":"Sattler","year":"2008","journal-title":"Top HIV Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.22038\/ijbms.2015.4404","article-title":"Adiponectin: an adipokine with protective features against metabolic syndrome","volume":"18","author":"Esfahani","year":"2015","journal-title":"Iran J Basic Med Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/1471-2334-14-347","article-title":"Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome","volume":"14","author":"Freitas","year":"2014","journal-title":"BMC Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1210\/jc.2007-1155","article-title":"Relationship of fat distribution with adipokines in human immunodeficiency virus infection","volume":"93","author":"Kosmiski","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.nut.2014.03.017","article-title":"Role of metabolic syndrome and antiretroviral therapy in adiponectin levels and oxidative stress in HIV-1 infected patients","volume":"30","author":"Morimoto","year":"2014","journal-title":"Nutrition"},{"key":"B44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.antiviral.2016.05.013","article-title":"Impact of elvitegravir on human adipocytes: alterations in differentiation, gene expression and release of adipokines and cytokines","volume":"132","author":"Moure","year":"2016","journal-title":"Antiviral Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s40265-013-0108-1","article-title":"HIV-associated lipodystrophy: impact of antiretroviral therapy","volume":"73","author":"Guaraldi","year":"2013","journal-title":"Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"ofx239","DOI":"10.1093\/ofid\/ofx239","article-title":"Weight gain: a possible side effect of all antiretrovirals","volume":"4","author":"Taramasso","year":"2017","journal-title":"Open Forum Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/QAD.0b013e32835705dd","article-title":"Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens","volume":"26","author":"Bigoloni","year":"2012","journal-title":"AIDS"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1468-1293.2010.00845.x","article-title":"The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy","volume":"12","author":"Cooper","year":"2011","journal-title":"HIV Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jac\/dkr058","article-title":"Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy","volume":"66","author":"Zhao","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/j.1532-5415.2009.02494.x","article-title":"Human immunodeficiency virus in an aging population, a complication of success","volume":"57","author":"Kirk","year":"2009","journal-title":"J Am Geriatr Soc."},{"key":"B51","first-page":"557","article-title":"A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia","volume":"39","author":"Amorosa","year":"2005","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jana.2010.04.002","article-title":"Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life","volume":"22","author":"Vance","year":"2011","journal-title":"J Assoc Nurses AIDS Care"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e109153","DOI":"10.1371\/journal.pone.0109153","article-title":"Body mass index and all-cause mortality in a large prospective cohort of white and black U","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1053\/j.gastro.2007.03.052","article-title":"The epidemiology of obesity","volume":"132","author":"Ogden","year":"2007","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"B56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"Reaven","year":"2011","journal-title":"Med Clin N Am."},{"key":"B57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11904-017-0368-6","article-title":"The fat of the matter: obesity and visceral adiposity in treated HIV infection","volume":"14","author":"Lake","year":"2017","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/00042560-200103010-00013","article-title":"Prevalence and predictive value of overweight in an urban HIV care clinic","volume":"26","author":"Shuter","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/2325957413488182","article-title":"Body mass index, immune status, and virological control in HIV-infected men who have sex with men","volume":"12","author":"Blashill","year":"2013","journal-title":"J Int Assoc Providers AIDS Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00126334-200001010-00011","article-title":"When obesity is desirable: a longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort","volume":"23","author":"Shor-Posner","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e0143740","DOI":"10.1371\/journal.pone.0143740","article-title":"Relationship between body mass index and mortality in HIV-infected HAART users in the women's interagency HIV study","volume":"10","author":"Sharma","year":"2015","journal-title":"PLoS ONE"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/QAD.0b013e328337fe01","article-title":"Obesity among HIV-infected persons: impact of weight on CD4 cell count","volume":"24","author":"Crum-Cianflone","year":"2010","journal-title":"AIDS"},{"key":"B63","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/cid\/cir606","article-title":"An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy","volume":"53","author":"Koethe","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.metabol.2007.03.008","article-title":"Obesity and immune cell counts in women","volume":"56","author":"Womack","year":"2007","journal-title":"Metabolism"},{"key":"B65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2007.12.004","article-title":"Drug use and other risk factors related to lower body mass index among HIV-infected individuals","volume":"95","author":"Quach","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"B66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/QAD.0000000000001709","article-title":"High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years","volume":"32","author":"McMahon","year":"2018","journal-title":"AIDS"},{"key":"B67","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","article-title":"Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals","volume":"73","author":"Herrin","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B68","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/QAD.0b013e32832913ee","article-title":"Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries","volume":"23","author":"Madec","year":"2009","journal-title":"AIDS"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3945\/ajcn.112.053728","article-title":"Weight change at 1 mo of antiretroviral therapy and its association with subsequent mortality, morbidity, and CD4 T cell reconstitution in a Tanzanian HIV-infected adult cohort","volume":"97","author":"Sudfeld","year":"2013","journal-title":"Am J Clin Nutr."},{"key":"B70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/QAI.0b013e3181b32baf","article-title":"Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia","volume":"53","author":"Koethe","year":"2010","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11904-012-0124-x","article-title":"The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care","volume":"9","author":"Samaras","year":"2012","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/QAI.0b013e31819c291b","article-title":"Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy","volume":"50","author":"Samaras","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1093\/jac\/dku295","article-title":"Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters","volume":"69","author":"Slama","year":"2014","journal-title":"J Antimicrob Chemother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4172\/2155-6113.1000545","article-title":"Oral Glucose Tolerance Testing identifies HIV+ infected women with Diabetes Mellitus (DM) not captured by standard DM definition","volume":"7","author":"Seang","year":"2016","journal-title":"J AIDS Clin Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12879-018-3221-7","article-title":"Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test\u2014which method to choose for the diagnosis?","volume":"18","author":"Coelho","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"17426","DOI":"10.7448\/IAS.15.2.17426","article-title":"Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"15","author":"Petoumenos","year":"2012","journal-title":"J Int AIDS Soc."},{"key":"B77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11904-016-0330-z","article-title":"Metabolic complications and glucose metabolism in HIV infection: a review of the evidence","volume":"13","author":"Willig","year":"2016","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11892-013-0369-9","article-title":"Diabetes and HIV: current understanding and future perspectives","volume":"13","author":"Kalra","year":"2013","journal-title":"Curr Diab Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.beem.2010.10.017","article-title":"Molecular mechanisms for insulin resistance in treated HIV-infection","volume":"25","author":"Hruz","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"B81","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"B82","doi-asserted-by":"publisher","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e25237","DOI":"10.1371\/journal.pone.0025237","article-title":"HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4","volume":"6","author":"Hresko","year":"2011","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity","volume":"279","author":"Hertel","year":"2004","journal-title":"J Biol Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12879-017-2254-7","article-title":"Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012","volume":"17","author":"Eyawo","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1468-1293.2007.00468.x","article-title":"Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area","volume":"8","author":"Martinez","year":"2007","journal-title":"HIV Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1468-1293.2008.00600.x","article-title":"Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984\u20132005","volume":"9","author":"Yang","year":"2008","journal-title":"HIV Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1071\/SH14084","article-title":"Changes in the prevalence of lipodystrophy, metabolic syndrome and cardiovascular disease risk in HIV-infected men","volume":"12","author":"Price","year":"2015","journal-title":"Sex Health"},{"key":"B93","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study","volume":"5","author":"Rickerts","year":"2000","journal-title":"Eur J Med Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S2352-3018(15)00077-6","article-title":"Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study","volume":"2","author":"Rasmussen","year":"2015","journal-title":"Lancet HIV"},{"key":"B96","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCULATIONAHA.108.790857","article-title":"Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)","volume":"119","author":"Worm","year":"2009","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B102","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/QAI.0000000000001450","article-title":"Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population","volume":"75","author":"Drozd","year":"2017","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B104","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Saves","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B105","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00126334-200208150-00002","article-title":"Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?","volume":"30","author":"Klein","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/655144","article-title":"Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study","volume":"51","author":"Lichtenstein","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e0147484","DOI":"10.1371\/journal.pone.0147484","article-title":"Pro-inflammatory markers in relation to cardiovascular disease in HIV infection","volume":"11","author":"Vos","year":"2016","journal-title":"PLoS ONE"},{"key":"B109","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/qai.0b013e3181b02e6a","article-title":"Untreated HIV infection and large and small artery elasticity","volume":"52","author":"Baker","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B110","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e59551","DOI":"10.1371\/journal.pone.0059551","article-title":"Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review","volume":"8","author":"Bavinger","year":"2013","journal-title":"PLoS ONE"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000317","article-title":"Cardiovascular disease-risk markers in HIV patients","author":"Asztalos","year":"2014","journal-title":"J AIDS Clin Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/078538902317338652","article-title":"Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement","volume":"34","author":"Mercie","year":"2002","journal-title":"Ann Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/dc08-1394","article-title":"Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"32","author":"Worm","year":"2009","journal-title":"Diab Care"},{"key":"B117","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/ciy146","article-title":"Higher risk of abdominal obesity, elevated LDL cholesterol and hypertriglyceridemia, but not of hypertension, in people living with HIV: results from the copenhagen comorbidity in HIV infection (COCOMO) study","volume":"67","author":"Gelpi","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/00042560-199511000-00009","article-title":"Weight loss prior to clinical AIDS as a predictor of survival","volume":"10","author":"Palenicek","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00042560-199805010-00012","article-title":"Weight loss as a predictor of survival and disease progression in HIV infection","volume":"18","author":"Wheeler","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00126334-200210010-00014","article-title":"Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy","volume":"31","author":"Tang","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B121","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fpubh.2016.00212","article-title":"Delayed effects of obese and overweight population conditions on all-cause adult mortality rate in the USA","volume":"4","author":"Okunade","year":"2016","journal-title":"Front Public Health"},{"key":"B122","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.2337\/dcS13-2023","article-title":"Obesity paradox does exist","volume":"36","author":"Hainer","year":"2013","journal-title":"Diab Care"},{"key":"B123","first-page":"672","article-title":"\u201cObesity paradox\u201d in chronic obstructive pulmonary disease","volume":"13","author":"Blum","year":"2011","journal-title":"Israel Med Assoc J."},{"key":"B124","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.amjmed.2007.05.011","article-title":"Obesity paradox in patients with hypertension and coronary artery disease","volume":"120","author":"Uretsky","year":"2007","journal-title":"Am J Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/archinte.165.1.55","article-title":"The obesity paradox: body mass index and outcomes in patients with heart failure","volume":"165","author":"Curtis","year":"2005","journal-title":"Arch Inter Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1729s","DOI":"10.3945\/ajcn.111.012070","article-title":"Conceptual framework for understanding the bidirectional links between food insecurity and HIV\/AIDS","volume":"94","author":"Weiser","year":"2011","journal-title":"Am J Clin Nutr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/QAD.0b013e32834884e6","article-title":"Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection","volume":"25","author":"Scherzer","year":"2011","journal-title":"AIDS"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T04:33:57Z","timestamp":1543293237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":127,"alternative-id":["10.3389\/fendo.2018.00705"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00705","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"article-number":"705"}}